Yuanzeng Min
- Biomedical Engineering top 1%
- Biomaterials top 0.5%
- Molecular Biology top 10%
- Materials Chemistry top 5%
- Oncology top 5%
- Co-authors
- Andrew Z. WangJoseph M. CasterMichael J. EblanYangzhong LiuBengang XingFang LiuJinming LiMing Da Lee
- Topics
- Nanoplatforms for cancer theranostics (22 papers)Immunotherapy and Immune Responses (16 papers)Nanoparticle-Based Drug Delivery (12 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Yuanzeng Min
55 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Biomedical Engineering 2.0k
- Biomaterials 1.5k
- Molecular Biology 1.3k
- Materials Chemistry 1.1k
- Oncology 826
Countries citing papers authored by Yuanzeng Min
This map shows the geographic impact of Yuanzeng Min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanzeng Min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanzeng Min more than expected).
Fields of papers citing papers by Yuanzeng Min
This network shows the impact of papers produced by Yuanzeng Min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanzeng Min. The network helps show where Yuanzeng Min may publish in the future.
Co-authorship network of co-authors of Yuanzeng Min
This figure shows the co-authorship network connecting the top 25 collaborators of Yuanzeng Min. A scholar is included among the top collaborators of Yuanzeng Min based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanzeng Min. Yuanzeng Min is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 40 | |
| 4 | 7 | |
| 5 | 23 | |
| 6 | 36 | |
| 7 | 7 | |
| 8 | 18 | |
| 9 | 54 | |
| 10 | 10 | |
| 11 | 63 | |
| 12 | 132 | |
| 13 | 159 | |
| 14 | 48 | |
| 15 | 88 | |
| 16 | 280 | |
| 17 | 11 | |
| 18 | 62 | |
| 19 | 24 | |
| 20 | 87 |
About Yuanzeng Min
Yuanzeng Min is a scholar working on Biomaterials, Oncology and Immunology, having authored 61 papers that have together received 4.0k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (22 papers), Immunotherapy and Immune Responses (16 papers) and Nanoparticle-Based Drug Delivery (12 papers). The work is most often cited by research in Biomaterials (1.5k citations), Biomedical Engineering (2.0k citations) and Oncology (826 citations). Yuanzeng Min has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Andrew Z. Wang, Joseph M. Caster, Michael J. Eblan, Yangzhong Liu, Bengang Xing, Fang Liu, Jinming Li, Ming Da Lee, Chengqiong Mao and Jun Wang. Their work appears in journals such as Chemical Reviews, Angewandte Chemie International Edition and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.